Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Willis Lease Finance (WLFC) Asset Writedowns and Impairment (2016 - 2025)

Willis Lease Finance's Asset Writedowns and Impairment history spans 16 years, with the latest figure at $10.2 million for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment rose 1586.12% year-over-year to $10.2 million; the TTM value through Sep 2025 reached $34.1 million, up 1087.54%, while the annual FY2024 figure was $11.2 million, 155.3% up from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $10.2 million at Willis Lease Finance, down from $11.5 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $21.1 million in Q1 2022 and bottomed at $49000.0 in Q4 2022.
  • The 5-year median for Asset Writedowns and Impairment is $1.9 million (2021), against an average of $4.3 million.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 98.64% in 2022 before it skyrocketed 3997.96% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $3.6 million in 2021, then plummeted by 98.64% to $49000.0 in 2022, then surged by 3997.96% to $2.0 million in 2023, then skyrocketed by 416.04% to $10.4 million in 2024, then dropped by 1.55% to $10.2 million in 2025.
  • Per Business Quant, the three most recent readings for WLFC's Asset Writedowns and Impairment are $10.2 million (Q3 2025), $11.5 million (Q2 2025), and $2.1 million (Q1 2025).